WA
GHDX

WFG Advisors’s Genomic Health, Inc. GHDX Stock Holding History

WFG Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-250
Closed -$5K – 1711
2015
Q3 		$5K Hold
250
– – ﹤0.01% 1281
2015
Q2 		$7K Hold
250
– – ﹤0.01% 1291
2015
Q1 		$8K Hold
250
– – ﹤0.01% 1274
2014
Q4 		$8K Hold
250
– – ﹤0.01% 1544
2014
Q3 		$7K Hold
250
– – ﹤0.01% 1597
2014
Q2 		$7K Hold
250
– – ﹤0.01% 1589
2014
Q1 		$7K Hold
250
– – ﹤0.01% 1564
2013
Q4 		$7K Hold
250
– – ﹤0.01% 1685
2013
Q3 		$8K Sell
250
-250
-50% -$8.36K ﹤0.01% 1613
2013
Q2 		$16K Buy
+500
New +$16.4K ﹤0.01% 1304

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

WFG Advisors's GHDX Position: Q4 2015 in Review

WFG Advisors sold out of Genomic Health, Inc. (GHDX) in Q4 2015, closing a stake of 250 shares — an estimated $5K sold.

WFG Advisors first reported a position in GHDX in Q2 2013 and held it in 10 quarters. The position peaked at $16K in Q2 2013. 132 funds tracked by Wall St. Rank hold GHDX as of Q4 2015.

  • WFG Advisors reported no remaining Genomic Health, Inc. position as of Q4 2015 after selling out during the quarter.
  • WFG Advisors sold 250 Genomic Health, Inc. shares in Q4 2015, an estimated $5K.
  • WFG Advisors first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 10 quarters.
  • WFG Advisors's Genomic Health, Inc. position peaked at $16K in Q2 2013.
  • 132 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2015.

Based on WFG Advisors's 13F filing for Q4 2015, filed 9 Feb 2016.